ArticleCancer immunology research2022

Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell-Mediated Antitumor Immune Responses.

Andrew Fedoriw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.